The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of ASKB589 (anti-Claudin 18.2 [CLDN18.2] monoclonal antibody) combined with CAPOX and PD-1 inhibitor as first-line treatment for locally advanced, relapsed and metastatic gastric/gastro-esophageal junction (G/GEJ) adenocarcinoma.
 
Zhi Peng
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Ying He
Employment - Jiangsu Aosaikang Biopharmaceutical Co., Ltd.
 
Jing Chen
Employment - Jiangsu Aosaikang Biopharmaceutical Co., Ltd.
 
Barbara Hickingbottom
No Relationships to Disclose
 
Jianfeng Lu
Employment - AskGene Pharma
Leadership - AskGene Pharma
Stock and Other Ownership Interests - AskGene Pharma
Travel, Accommodations, Expenses - AskGene Pharma